By Kirstin R Matthews, Bhavana Kunisetty and Keri Sprung
The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report. Stem Cells and Development: http://bit.ly/2CrEDEj.
Sept. 6, 2018, 3:27 p.m.